← Back to headlines
AbbVie Inc. Signs Licensing Agreement for Development of Pain Medicines
AbbVie Inc. (ABBV) has entered into a licensing agreement aimed at the development of new pain medicines, signaling a strategic move in its pharmaceutical portfolio.
22 Apr, 21:51 — 22 Apr, 21:51
Sources
Showing 1 of 1 sources
